Lasofoxifene in Postmenopausal Women with Osteoporosis-Reference-Cited by-同舟云学术

Lasofoxifene in Postmenopausal Women with Osteoporosis

Published:2010-02-25 Issue:8 Volume:362 Page:686-696
ISSN:0028-4793
Container-title:New England Journal of Medicine
language:en
Short-container-title:N Engl J Med

Author:

Cummings Steven R.,Ensrud Kristine,Delmas Pierre D.,LaCroix Andrea Z.,Vukicevic Slobodan,Reid David M.,Goldstein Steven,Sriram Usha,Lee Andy,Thompson John,Armstrong Roisin A.,Thompson David D.,Powles Trevor,Zanchetta Jose,Kendler David,Neven Patrick,Eastell Richard

Publisher

Massachusetts Medical Society

Subject

General Medicine

Link

http://www.nejm.org/doi/pdf/10.1056/NEJMoa0808692

Cited by 328 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Precision therapeutics and emerging strategies for HR-positive metastatic breast cancer;Nature Reviews Clinical Oncology;2024-08-23

2. The relationship between treatment-related changes in total hip BMD measured after 12, 18, and 24 mo and fracture risk reduction in osteoporosis clinical trials: the FNIH-ASBMR-SABRE project;Journal of Bone and Mineral Research;2024-08-04

3. Novel Treatment Strategies for Hormone Receptor (HR)-Positive, HER2-Negative Metastatic Breast Cancer;Journal of Clinical Medicine;2024-06-20

4. Pre-treatment bone mineral density and the benefit of pharmacologic treatment on fracture risk and BMD change: analysis from the FNIH-ASBMR SABRE project;Journal of Bone and Mineral Research;2024-05-01

5. Oral lasofoxifene's effects on moderate to severe vaginal atrophy in postmenopausal women: two phase 3, randomized, controlled trials;Menopause;2024-04-23